Hi all first glance and quick read of the $ income/expense sheet.
The % represents the amount of the total loss figure of $22,140,245.
Yes I am aware of other aspects of the figures must also be considered. However one must look at what -has been/could/will be a 'shareholder benefit' Only you as a shareholder may/can/will assess this now or in time.
I do not begrudge any Director etc of benefits,subject to those that subscribe the most $$$$$$ (s/holders) as per my comments above. Also are you a long term investor or just after cap. gains - quite different strategies and as one can see from posters comments.
28% $ 6,287,822 Research & Development
38% $ 8,356,351 Employee Benefits (Item 8)
8% $ 1,849,444 Share Benefits - mainly Directors (Item 8 -17)
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4D and Half Year Financial Report
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$5.91

Ann: Appendix 4D and Half Year Financial Report, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
0.000(0.00%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 857 | $5.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 260 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 3000 | 5.620 |
1 | 1000 | 5.610 |
2 | 3500 | 5.600 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 260 | 1 |
6.180 | 50 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
Last trade - 07.00am 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online